/PRNewswire/ Capsida Biotherapeutics, Inc., an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies.
/PRNewswire/ Capsida Biotherapeutics Inc., an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies.
A new grant funds a collaboration of Caltech researchers
and collaborators to study the connections between the gut and the brain and how this circuitry may affect Parkinson s disease